Second degree AV block primary prevention: Difference between revisions
| Line 5: | Line 5: | ||
==Overview== | ==Overview== | ||
Pacemaker implantations as a treatment for atrioventricular (AV) block are increasing worldwide. Prevention strategies for AV block are lacking because modifiable risk factors have not yet been identified. | Pacemaker implantations as a treatment for atrioventricular (AV) block are increasing worldwide. Prevention strategies for AV block are lacking because modifiable risk factors have not yet been identified.Atrioventricular (AV) block is a common reason for pacemaker implantation, and the number of pacemaker implantations is increasing.1 Atrioventricular block most commonly occurs in the absence of significant cardiac disease and is generally attributed to idiopathic fibrosis of the conduction system.2 By definition, the cause of that fibrosis remains unknown. | ||
==Primary prevention== | ==Primary prevention== | ||
Revision as of 20:07, 9 April 2020
|
Second degree AV block Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Second degree AV block primary prevention On the Web |
|
American Roentgen Ray Society Images of Second degree AV block primary prevention |
|
Risk calculators and risk factors for Second degree AV block primary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
Pacemaker implantations as a treatment for atrioventricular (AV) block are increasing worldwide. Prevention strategies for AV block are lacking because modifiable risk factors have not yet been identified.Atrioventricular (AV) block is a common reason for pacemaker implantation, and the number of pacemaker implantations is increasing.1 Atrioventricular block most commonly occurs in the absence of significant cardiac disease and is generally attributed to idiopathic fibrosis of the conduction system.2 By definition, the cause of that fibrosis remains unknown.
Primary prevention
- Pacemaker implantations as a treatment for atrioventricular (AV) block are increasing worldwide. Prevention strategies for AV block are lacking because modifiable risk factors have not yet been identified[1].
References
- ↑ Kerola T, Eranti A, Aro AL, Haukilahti MA, Holkeri A, Junttila MJ, Kenttä TV, Rissanen H, Vittinghoff E, Knekt P, Heliövaara M, Huikuri HV, Marcus GM (May 2019). "Risk Factors Associated With Atrioventricular Block". JAMA Netw Open. 2 (5): e194176. doi:10.1001/jamanetworkopen.2019.4176. PMC 6632153 Check
|pmc=value (help). PMID 31125096.